Pharmaceutical

UAE approves BioArctic and Eisai’s Leqembi for Alzheimer’s disease

The Ministry of Health and Prevention in the UAE has granted approval for BioArctic and Eisai’s Leqembi for Alzheimer's disease.

Aug 15, 2024 - 04:00
UAE approves BioArctic and Eisai’s Leqembi for Alzheimer’s disease
The Ministry of Health and Prevention in the UAE has granted approval for BioArctic and Eisai’s Leqembi for Alzheimer's disease.
Read the original article

Tags:

Previous Article

NorthStar and Convergent expand deal for prostate cancer drug

Next Article

China approves AstraZeneca-Daiichi Sankyo’s gastric cancer therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

Opinion: Compounding pharmacies offer a fix for shortag...

May 15, 2023

Replimune kickstarts Phase III melanoma trial studying RP1 immunotherapy

Replimune kickstarts Phase III melanoma trial studying ...

Aug 15, 2024

Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb

Meet the fetal surgeon forging CRISPR’s next frontier: ...

Feb 21, 2024